Chart: FDA Recalls & Court Actions
Executive Summary
FDA Recalls & Court Actions
You may also be interested in...
Vintage Sulfazine EC recall (correction)
A recall of Sulfazine EC (sulfasalazine delayed release) listed in FDA's April 6 Enforcement Report incorrectly describes it as occurring in 2005 (1"The Pink Sheet" April 11, 2005, p. 33). "On March 4, 2004 Vintage Pharmaceuticals Inc. sent a letter to Qualitest Pharmaceuticals recalling these two lots," Vintage said. "On March 8, 2004 Qualitest Pharmaceuticals sent a letter to its wholesale customers recalling these two lots. Vintage submitted a closeout package for the recall to FDA on April 7, 2005"...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials